Synthesis of Pyridopyrazine-1,6-dione γ-Secretase Modulators via Selective 4-Methylimidazole N1-Buchwald Arylation.
暂无分享,去创建一个
N. Sach | Christopher W. am Ende | Danica A Rankic | J. Humphrey | M. Pettersson | Longfei Xie | Subbas Sakya | D. A. Rankic
[1] Christopher W. am Ende,et al. Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. , 2017, The Journal of organic chemistry.
[2] Thomas Mcinally,et al. Investigating Scale-Up and Further Applications of DABAL-Me3 Promoted Amide Synthesis , 2015 .
[3] Gregory W. Kauffman,et al. Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability. , 2015, ACS medicinal chemistry letters.
[4] Gregory W. Kauffman,et al. Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. , 2015, Bioorganic & medicinal chemistry letters.
[5] D. Irvine,et al. On DABAL-Me3 promoted formation of amides , 2013 .
[6] Gregory W. Kauffman,et al. Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012 , 2013, Expert opinion on therapeutic patents.
[7] Christopher W. am Ende,et al. Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction. , 2013, Organic letters.
[8] Gregory W. Kauffman,et al. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators. , 2012, Bioorganic & medicinal chemistry letters.
[9] S. Buchwald,et al. Completely N1-selective palladium-catalyzed arylation of unsymmetric imidazoles: application to the synthesis of nilotinib. , 2012, Journal of the American Chemical Society.
[10] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[11] Alzheimer’s Association,et al. 2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.
[12] S. Woodward. Design versus Discovery in Synthetic Applications of Organoalanes , 2007 .
[13] S. Woodward,et al. Amide bond formation using an air-stable source of AlMe3 , 2006 .
[14] K. Wehrstedt,et al. Explosive properties of 1-hydroxybenzotriazoles. , 2005, Journal of hazardous materials.
[15] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[16] Martin Pettersson,et al. γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease , 2017 .